
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
GENERAL COMMENTARY article
Front. Endocrinol. , 09 June 2015
Sec. Cancer Endocrinology
Volume 6 - 2015 | https://doi.org/10.3389/fendo.2015.00098
This article is part of the Research Topic Transcriptional Regulation in Cancers and Metabolic Diseases View all 13 articles
This article is a commentary on:
Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
A corrigendum on
In Table 2, the section designated “Disabling of cell survival pathway gene expression,” line 5 incorrectly states “…pro-apoptotic miR-21”; the correct statement is “…pro-apoptotic miR-15A.” The issue is correctly discussed in the body of the published text, p. 2, right column, paragraph 4.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: integrin, thyroid hormone, tetraiodothyroacetic acid (tetrac), nano particle, gene expression, corrigendum
Citation: Davis PJ, Glinsky GV, Lin H-Y, Leith JT, Hercbergs A, Tang H-Y, Ashur-Fabian O, Incerpi S and Mousa SA (2015) Corrigendum: “Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac”. Front. Endocrinol. 6:98. doi: 10.3389/fendo.2015.00098
Received: 27 May 2015; Accepted: 27 May 2015;
Published: 09 June 2015
Edited by:
Wen Zhou, Columbia University, USAReviewed by:
Jean-Yves Scoazec, Université Lyon 1, FranceCopyright: © 2015 Davis, Glinsky, Lin, Leith, Hercbergs, Tang, Ashur-Fabian, Incerpi and Mousa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paul J. Davis,cGRhdmlzLm9yZHdheXN0QGdtYWlsLmNvbQ==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.